Thanks to all for this ongoing discussion. With s

Thanks to all for this ongoing discussion. With so many opinions and comments it's difficult to be succinct. It is disappointing, but there really was no viable reason to pursue the dividend. I don't see how it could even be called a dividend. It was merely a forward split that would bring us down to .40. That would require a 500% increase to get us to the NASDAQ minimum. It would also be a signal to increase shorting, because the strength of the company would appear to be diminished. In fact, it is diminished until the Creek fiasco is resolved.

Cramer says that "hope is never an investment strategy". However, we can only hope that there are PR's lined up to show true progress. Another major factor is the terms assigned to the $40M that will be announced through the S1. Joe has seen enough damage caused by previous toxic funding. My opinion is that he has negotiated terms that are at least non-toxic. Of course, the next step is just as important. What does Generex do with the money? Does it indeed increase shareholder value and move the pps to the $2 mark or higher.

I don't know the status of the NGIO spin-off. However, I do know that I have thousands of shares with an unassigned value. If that value can be realized (a big if), it will go a long way to getting us on to NASDAQ. At some point does Merck decide to take the plunge and marry us, or will we be left at the altar.

The holiday is over, but "the Holidays" are just around the corner. Joe has a lot of work to do if things are going to turn around. He has to convince the other partners that their shares are restricted and untradeable. He has to meet with Generex' attorneys and find a way to stop the bleeding from Creek. I'm not sure investors can be made whole, but that has to be a goal. On top of that he still has to complete his every day functions with diminished physical abilities. (BTW, for those who believe in prayer, prayer is in order for the man. He has suffered and continues to suffer, physically and mentally.)

Today it seems that Generex is herding cats. Already there were many moving parts that needed to come together. Now there are even more. It is the CEO's responsibility to foster confidence in Generex; confidence in individual investors, institutional investors, the market, and the Street. I don't believe that we individual investors are privy to enough information to provide advice, but I have read some legitimate suggestions. However, most of us have Joe's back, because he has repeatedly told us that his skin in the game is greater than anyone's. We succeed or fail together. I believe him, but that's only my personal decision.

Each investor needs to take inventory of his/her portfolio and decide to stay or bail. If Generex is more than 20% of a meaningful portion of your portfolio, you have hard decisions to make. By "meaningful" I mean that it is designated for retirement, a child's education, purchase of a home, or some other integral part of your life. For the rest of us, it is merely "wait and see". What is the alternative?

Finally, the stink of Old Generex will always return when problems like Creek's betrayal arise. I'm sure Creek will provide legal justification (in their opinion) for their actions. They have no choice but to become entrenched in their position. This isn't the fault of Joe or the new management team. I think that is the sentiment we are hearing from Orlando John. Mr. Market will not give Generex the benefit of the doubt. Neither will those who have over-invested and find themselves under water (again in some cases).

That's my summary. I wish I was a more sophisticated investor, but I'm not. I've made lots of mistakes, and have tried to use them in order to not repeat them. The last point is that "it is what it is". Each investor can read into it what they see. That's small comfortable, but let's face it, we are not in a comfortable position at this point of Generex' development.